The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
Nearly US$ 13 billion has been pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria, to accelerate the response to end these diseases over the next three years.
Zambian officials promote absitinence in prisons, turning a blind eye to the HIV prevention needs of men who have sex with men
The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.
The Gates Foundation awards grant to expand access to pre-exposure prophylaxis (PrEP) for key populations in Kenya.
Sex workers in Burundi have more negotiating power to demand safer sex, thanks to efforts to help them find new ways of earning an income.
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference in Durban, South Africa heard last month.
The world’s largest drug consumption facility has opened in Copenhagen, Denmark, giving people who use drugs a safe place to use illicit substances in a way that will limit harm to themselves, and to those around them.
Heightened concerns regarding the link between the hormonal contraceptive, Depo-Provera, and the risk of HIV acquisition in women after new systematic review released.
Meaningful inclusion of young people is key to effective HIV programming, says Lehlohonolo Mohasoa. And young people are our greatest hope in ending AIDS.
AVERT Chief Executive, Sarah Hand, reflects on the biannual International AIDS Conference (AIDS 2016) in Durban, and where we should focus our efforts for an effective HIV response going forward.